Michael J. Pacilio, Exelon Nuclear’s president and chief nuclear officer since 2010, has been named executive vice president and chief operating officer of Exelon Generation LLC, the company announced, which is a business unit of Exelon Generation, which is a subsidiary of Exelon Corporation (NYSE:EXC). Bryan Hanson, Exelon Nuclear COO, has been promoted to senior vice president, Exelon Generation, and president and chief nuclear officer of Exelon Nuclear, replacing Pacilio. Exelon Corporation (NYSE:EXC) in last trading activity advanced 0.14% to close at $36.27. Company weekly performance is -4.80% while its quarterly performance stands at 5.22%. Exelon Corporation (NYSE:EXC) is -6.83% away from its 52 week high.
Insulet Corporation (NASDAQ:PODD), Wednesday lowered its revenue outlook for the fourth quarter and full year 2014 due to a delay in shipments of its non-insulin drug delivery products, sending its shares down nine percent in the after hours trading. Insulet Corporation (NASDAQ:PODD) in last trading activity advanced 2.39% to close at $44.53. Company weekly performance is -3.74% while its quarterly performance stands at 18.68%. Insulet Corporation (NASDAQ:PODD) is -13.21% away from its 52 week high.
Brean Capital assumed coverage on shares of Cardiome Pharma Corp (NASDAQ:CRME) in a report issued on Wednesday, TheFlyOnTheWall.com reports. The firm issued a buy rating on the stock. Cardiome Pharma Corp. (NASDAQ:CRME) has 10.37% insider ownership while its institutional ownership stands at 76.60%. In last trading activity company’s stock closed at $9.30.
Boulder Brands (NASDAQ:BDBD) CEO Stephen B. Hughes sold 10,000 shares of Boulder Brands stock on the open market in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $10.69, for a total value of $106,900.00. On Wednesday shares of Boulder Brands, Inc. (NASDAQ:BDBD) closed at $10.35. Company’s sales growth for last 5 years was 15.80% and EPS growth for next 5 years is recorded as 20.00%.
On Jan 05, Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) announced that Pratik Shah, Ph.D., President and Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 11:30 a.m. PST at the Westin St. Francis in San Francisco. On last trading day Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) advanced 2.88% to close at $52.24. Its volatility for the week is 6.29% while volatility for the month is 5.54%. Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) monthly performance is 120.33%.